Genzyme rejects Sanofi's $18.5B offer

Sanofi-Aventis has finally gone public with its offer for Genzyme. But Genzyme announced its definite rejection of that bid; so the news is not just sources volleying in the media anymore. However, with no rival bidder in sight, it behooves Sanofi to drag out any eventual negotiations, analysts say. Report